Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Buspirone for Gastroparesis Symptoms (BESST)
NCT03587142Phase 2Completed
- Sponsor
- Johns Hopkins Bloomberg School of Public Health
- Start
- Aug 2019
- Primary completion
- Apr 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of buspirone in gastroparesis, sponsored by Johns Hopkins Bloomberg School of Public Health. Started Aug 2019; status: completed.
02
Drugs
buspirone
03
Conditions
gastroparesis
Beyond the preview
Go deeper on NCT03587142.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03587142.